171 related articles for article (PubMed ID: 37373014)
41. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.
Abdel-Rahman WM; Al-Khayyal NA; Nair VA; Aravind SR; Saber-Ayad M
World J Gastroenterol; 2017 May; 23(19):3440-3448. PubMed ID: 28596680
[TBL] [Abstract][Full Text] [Related]
42. The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin.
Almendro V; Ametller E; García-Recio S; Collazo O; Casas I; Augé JM; Maurel J; Gascón P
PLoS One; 2009; 4(3):e4728. PubMed ID: 19266094
[TBL] [Abstract][Full Text] [Related]
43. Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells.
Liu HF; Hu HC; Chao JI
Chem Biol Interact; 2010 Dec; 188(3):535-45. PubMed ID: 20708607
[TBL] [Abstract][Full Text] [Related]
44. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.
Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW
Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244
[TBL] [Abstract][Full Text] [Related]
45. WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling.
Cai J; Su L; Luo W
Bioengineered; 2022 Jun; 13(6):14450-14459. PubMed ID: 35758246
[TBL] [Abstract][Full Text] [Related]
46. Pramanicin analog induces apoptosis in human colon cancer cells: critical roles for Bcl-2, Bim, and p38 MAPK signaling.
Bodur C; Kutuk O; Karsli-Uzunbas G; Isimjan TT; Harrison P; Basaga H
PLoS One; 2013; 8(2):e56369. PubMed ID: 23441183
[TBL] [Abstract][Full Text] [Related]
47. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
48. Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells.
Chen HY; Islam A; Yuan TM; Chen SW; Liu PF; Chueh PJ
J Exp Clin Cancer Res; 2018 Jul; 37(1):161. PubMed ID: 30029680
[TBL] [Abstract][Full Text] [Related]
49. Malformin A1 treatment alters invasive and oncogenic phenotypes of human colorectal cancer cells through stimulation of the p38 signaling pathway.
Park SY; Oh HH; Park YL; Yu HM; Myung DS; Cho SB; Lee WS; Park D; Joo YE
Int J Oncol; 2017 Sep; 51(3):959-966. PubMed ID: 28713983
[TBL] [Abstract][Full Text] [Related]
50. Supramolecular Chemotherapy: Carboxylated Pillar[6]arene for Decreasing Cytotoxicity of Oxaliplatin to Normal Cells and Improving Its Anticancer Bioactivity Against Colorectal Cancer.
Hao Q; Chen Y; Huang Z; Xu JF; Sun Z; Zhang X
ACS Appl Mater Interfaces; 2018 Feb; 10(6):5365-5372. PubMed ID: 29355009
[TBL] [Abstract][Full Text] [Related]
51. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353
[TBL] [Abstract][Full Text] [Related]
52. Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells.
Wang M; Xiang Y; Wang R; Zhang L; Zhang H; Chen H; Luan X; Chen L
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431875
[TBL] [Abstract][Full Text] [Related]
53. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.
Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M
Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584
[TBL] [Abstract][Full Text] [Related]
54. Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo.
Howells LM; Sale S; Sriramareddy SN; Irving GR; Jones DJ; Ottley CJ; Pearson DG; Mann CD; Manson MM; Berry DP; Gescher A; Steward WP; Brown K
Int J Cancer; 2011 Jul; 129(2):476-86. PubMed ID: 20839263
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53.
Borralho PM; Moreira da Silva IB; Aranha MM; Albuquerque C; Nobre Leitão C; Steer CJ; Rodrigues CM
Biochim Biophys Acta; 2007 Jan; 1772(1):40-7. PubMed ID: 17056233
[TBL] [Abstract][Full Text] [Related]
56. The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines.
Bajbouj K; Schulze-Luehrmann J; Diermeier S; Amin A; Schneider-Stock R
BMC Complement Altern Med; 2012 May; 12():69. PubMed ID: 22640402
[TBL] [Abstract][Full Text] [Related]
57. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.
Arango D; Wilson AJ; Shi Q; Corner GA; Arañes MJ; Nicholas C; Lesser M; Mariadason JM; Augenlicht LH
Br J Cancer; 2004 Nov; 91(11):1931-46. PubMed ID: 15545975
[TBL] [Abstract][Full Text] [Related]
58. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells.
Zhou QM; Wang S; Zhang H; Lu YY; Wang XF; Motoo Y; Su SB
Acta Pharmacol Sin; 2009 Dec; 30(12):1648-58. PubMed ID: 19960010
[TBL] [Abstract][Full Text] [Related]
59. Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.
Willms A; Schittek H; Rahn S; Sosna J; Mert U; Adam D; Trauzold A
PLoS One; 2019; 14(4):e0214847. PubMed ID: 30947287
[TBL] [Abstract][Full Text] [Related]
60. Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade.
Chang HL; Chen CY; Hsu YF; Kuo WS; Ou G; Chiu PT; Huang YH; Hsu MJ
Biochim Biophys Acta; 2013 Aug; 1830(8):4053-64. PubMed ID: 23583370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]